HC Wainwright & Co. Reiterates Buy on Corbus Pharmaceuticals, Maintains $35 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains $35 price target.
Stocks · News reference
Market-Moving News for September 14th
GLW: -8% | Corning shares are trading lower after the company announced a $2 billion offering. ELMT: 49% | Elmet Group Lands $450M US Government Investment To Expand Tungsten Manufacturing, To Invest More Than $165M
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Corbus Pharmaceuticals Obesity Drug Avoids 'Depressive Effects'
Corbus Pharmaceuticals reports positive Phase 1b trial results for obesity drug CRB-913, demonstrating significant 12-week weight loss.
Corbus Pharma Announces Topline Data From CANYON-1 Phase 1b Trial Of CRB-913 Demonstrating Statistically Significant And Clinically Meaningful Weight Loss In Obesity
CRB-913 demonstrated statistically significant and clinically meaningful mean weight loss of 5% at 60 mg after 12 weeks with no plateau observed CRB-913 was generally well tolerated with psychiatric adverse events
8-K filing — Elmet Group Co. (ELMT)
Filed: 2026-09-24 AccNo: 0001213900-26-102840 Size: 911 KB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
The Elmet Group to Invest Approximately $125 Million in Masan High-Tech Materials to Strengthen Tungsten Supply Chain
The Elmet Group announced a $124.75 million investment to acquire a 4.99% equity stake in Vietnam-based Masan High-Tech Materials Corporation, formalizing a 12-year commercial relationship. The deal includes long-term supply agreements for mined tungsten from the Nui Phao Mine and tungsten conversion services. This investment strengthens the tungsten supply chain and follows a $450 million U.S. Government commitment to support critical materials infrastructure.
Elmet Group Secures 4.99% Stake In Vietnam-based Masan High-Tech Materials For $124.75M, Signs Multi-Year Tungsten Supply Agreements
Two industry leaders formalize strategic relationship spanning the full tungsten value chainInvestment includes a 4.99% ownership stake and multi-year supply agreements across key production stagesFurther advances the